Citation: Gupta, K
In vulnerable people, this can become a tipping point
GLP-1 receptor agonists such as Ozempic, Wegovy, and Mounjaro are increasingly prescribed for obesity and type 2 diabetes due to their proven effectiveness in reducing appetite, promoting weight loss, and lowering blood glucose levels.(1, 2) These medications have become extremely popular, fueled by extensive marketing to both healthcare providers and the public
For gut healing applications, some practitioners recommend dosing around meals in specific patterns
Very efficient, and doable Love the feeling
With RTDs, the de-facto NO booster is L-citrulline , the amino acid that helps the body produce more L-arginine , which subsequently converts to nitric oxide (NO)